ARTICLE SUMMARY:
A tablet-based app, biofeedback protocol, and custom sensor form the basis for the Freespira, a new therapy that targets the dysfunctional breathing and low exhaled CO2 levels that contribute to the symptoms of panic disorder.
For those who suffer from panic disorder, the greatest fear is fear itself. In the US, 27 million people have panic attacks each year, and six million of them, with attacks so frequent that they live in constant fear, are diagnosed with panic disorder.
